# Iohexol-Tromethamine

## Omnipaque 350mg I/mL 100mL

| 藥物代碼 | IOMN1 |
| :--- | :--- |
| 適應症 | 脊髓造影, 血管造影, 電腦斷層掃描增強造影劑, 泌尿道造影Intrathecal: Myelography; contrast enhancement for computerized tomography Intravascular: Angiocardiography, aortography, digital subtraction angiography, peripheral arteriography, excretory urography; contrast enhancement for computed tomographic imaging Oral/body cavity: Arthrography, GI tract examination, hysterosalpingography, pancreatography, cholangiopancreatography, herniography, cystourethrography; enhanced computed tomography of the abdomen |
| 副作用 | 全身溫熱感, 暫時性金屬味道, 腹部不適, 噁心, 嘔吐, 過敏性反應Cardiovascular: Asystole, arrhythmia, bradycardia, cardiopulmonary collapse, edema, heart failure, hypertension \(in patients with phenochromocytoma after intra-arterial injection\), hypotension, syncope, transient ischemic attacks, vasovagal attacks, venous thrombosis, ventricular fibrillation, ventricular tachycardiaCentral nervous system: Anxiety, confusion, dizziness, headache, loss of consciousness, seizure, vertigoDermatologic: Pruritus, rash, urticariaEndocrine & metabolic: Thyrotoxicosis exacerbationGastrointestinal: Cramping, diarrhea, nausea, salivary gland swelling, vomitingLocal: Burning sensation, pain at injection site, thrombophlebitisNeuromuscular & skeletal: Parasthesia, polyarthropathy, tremorOcular: Vision abnormalitiesRenal: Contrast-associated nephropathy, creatinine increased, renal dysfunctionRespiratory: Bronchospasm, cough, dyspnea, pulmonary edema, rhinitis, sneezingMiscellaneous: Anaphylactoid reaction, diaphoresis, hypersensitivity reactions |
| 禁忌 | Hypersensitivity to iohexol or any component of the formulation. |
| 藥物保存方式 | N/A |
| 用法用量 | Dosing is based numerous variables including: type of examination, route of administration, patient age/weight and product. Consult specific product information for detailed dosing. Intrathecal route: Myelogram a\) Lumbosacral:The usual recommended dose for use in lumbar myelography is 10 to 17 milliliters of iohexol 180 milligrams iodine/milliliter \(mgI/mL\) or 7 to 12.5 milliliters of iohexol 240 mgI/mL administered by lumbar injection. b\) Thoracic:The usual recommended dose for thoracic myelography is 6 to 12.5 milliliters of iohexol 240 milligrams iodine/milliliter \(mgI/mL\) or 6 to 10 mL of iohexol 300 mgI/mL administered by lumbar or cervical injection. c\) Cervical:For cervial myelography given by lumbar injections, the following doses have been used: 6 to 12.5 milliliters of iohexol 240 milligrams iodine/milliliter\(mgI/mL\) or 6 to 10 mL of iohexol 300 mgI/mL. If iohexol is administered by C1-2 injection, the recommended dose is 7 to 10 mL of iohexol 180 mgI/mL, 6 to 12.5 mL of iohexol 240 mgI/mL, or 4 to 10 mL of iohexol 300 mgI/mL. d\) Spinal cord:The usual dose for total columnar myelography \(lumbar injection\) is 6 to 12.5 milliliters of iohexol 240 milligrams iodine/milliliter\(mgI/mL\) or 6 to 10 mL of iohexol 300 mgI/mL. Intravascular route: CT of head The recommended dose for HEAD IMAGING is 70 to 150 milliliters of iohexol 300 milligram iodine/milliliter \(mgI/mL\) or 80 mL of iohexol 350 mgI/mL by injection or 120 to 250 mL of iohexol 240 mgI/mL by infusion. For BODY IMAGING the dose is 50 to 200 mL of iohexol 300 mgI/mL or 60 to 100 mL of iohexol 350 mgI/mL by injection. Angiocardiography a\) DOSAGE SUMMARY:Iohexol 350 milligrams iodine/milliliter is recommended for use in ANGIOCARDIOGRAPHY. b\) VENTRICULOGRAPHY:The usual adult volume is a single injection of 40 milliliters \(mL\) of iohexol 350 milligrams iodine/mL \(range 30 mL to 60 mL\) \[24\]\[25\]\[26\]. This may be repeated as necessary. When combined with selective coronary arteriography the total administered dose should not exceed 250 milliliters \(87.5 grams iodine\). c\) SELECTIVE CORONARY ARTERIOGRAPHY:The usual adult dose for right or left coronary arteriography is 5 milliliters \(mL\) of iohexol 350 milligrams iodine/mL \(range 3 mL to 14 mL\) per injection. |
| 肝功能異常 | 無需調整劑量  需調整劑量 |
| 腎功能異常 | 無需調整劑量  需調整劑量 |
| 懷孕用藥危分級 | 可能安全 |
| 孕期用藥建議 | N/A |
| 附帶說明 | N/A |
| 哺乳期用藥建議 | Unknown 尚未建立 |
| 附帶說明 | N/A |
| 注射劑給藥建議途徑 | IA, IV, IVP, IVPUSH, R, RECT |
| 乾粉稀釋液 | N/A |
| 輸注點滴液 | N/A |
| IVP 用法建議 | N/A |
| IVD 用法建議 | N/A |
| 注意事項 | 1.體腔使用途徑以水稀釋, 成人兒童及部位不同依1:1~1:50不等比例稀釋 2.腎功能正常病患應立即停用Meformin 48小時,待腎功能恢復後再啟用;如腎功能不佳病患,請評估病患情況,提前48小時停用Meformin. |

## Omnipaque 350mg I/mL 200mL

| 藥物代碼 | IOMN2 |
| :--- | :--- |
| 適應症 | 脊髓造影, 血管造影, 電腦斷層掃描增強造影劑, 泌尿道造影Intrathecal: Myelography; contrast enhancement for computerized tomography Intravascular: Angiocardiography, aortography, digital subtraction angiography, peripheral arteriography, excretory urography; contrast enhancement for computed tomographic imaging Oral/body cavity: Arthrography, GI tract examination, hysterosalpingography, pancreatography, cholangiopancreatography, herniography, cystourethrography; enhanced computed tomography of the abdomen |
| 副作用 | 全身溫熱感, 暫時性金屬味道, 腹部不適, 噁心, 嘔吐, 過敏性反應Cardiovascular: Asystole, arrhythmia, bradycardia, cardiopulmonary collapse, edema, heart failure, hypertension \(in patients with phenochromocytoma after intra-arterial injection\), hypotension, syncope, transient ischemic attacks, vasovagal attacks, venous thrombosis, ventricular fibrillation, ventricular tachycardiaCentral nervous system: Anxiety, confusion, dizziness, headache, loss of consciousness, seizure, vertigoDermatologic: Pruritus, rash, urticariaEndocrine & metabolic: Thyrotoxicosis exacerbationGastrointestinal: Cramping, diarrhea, nausea, salivary gland swelling, vomitingLocal: Burning sensation, pain at injection site, thrombophlebitisNeuromuscular & skeletal: Parasthesia, polyarthropathy, tremorOcular: Vision abnormalitiesRenal: Contrast-associated nephropathy, creatinine increased, renal dysfunctionRespiratory: Bronchospasm, cough, dyspnea, pulmonary edema, rhinitis, sneezingMiscellaneous: Anaphylactoid reaction, diaphoresis, hypersensitivity reactions |
| 禁忌 | Hypersensitivity to iohexol or any component of the formulation. |
| 藥物保存方式 | N/A |
| 用法用量 | Dosing is based numerous variables including: type of examination, route of administration, patient age/weight and product. Consult specific product information for detailed dosing. Intrathecal route: Myelogram a\) Lumbosacral:The usual recommended dose for use in lumbar myelography is 10 to 17 milliliters of iohexol 180 milligrams iodine/milliliter \(mgI/mL\) or 7 to 12.5 milliliters of iohexol 240 mgI/mL administered by lumbar injection. b\) Thoracic:The usual recommended dose for thoracic myelography is 6 to 12.5 milliliters of iohexol 240 milligrams iodine/milliliter \(mgI/mL\) or 6 to 10 mL of iohexol 300 mgI/mL administered by lumbar or cervical injection. c\) Cervical:For cervial myelography given by lumbar injections, the following doses have been used: 6 to 12.5 milliliters of iohexol 240 milligrams iodine/milliliter\(mgI/mL\) or 6 to 10 mL of iohexol 300 mgI/mL. If iohexol is administered by C1-2 injection, the recommended dose is 7 to 10 mL of iohexol 180 mgI/mL, 6 to 12.5 mL of iohexol 240 mgI/mL, or 4 to 10 mL of iohexol 300 mgI/mL. d\) Spinal cord:The usual dose for total columnar myelography \(lumbar injection\) is 6 to 12.5 milliliters of iohexol 240 milligrams iodine/milliliter\(mgI/mL\) or 6 to 10 mL of iohexol 300 mgI/mL. Intravascular route: CT of head The recommended dose for HEAD IMAGING is 70 to 150 milliliters of iohexol 300 milligram iodine/milliliter \(mgI/mL\) or 80 mL of iohexol 350 mgI/mL by injection or 120 to 250 mL of iohexol 240 mgI/mL by infusion. For BODY IMAGING the dose is 50 to 200 mL of iohexol 300 mgI/mL or 60 to 100 mL of iohexol 350 mgI/mL by injection. Angiocardiography a\) DOSAGE SUMMARY:Iohexol 350 milligrams iodine/milliliter is recommended for use in ANGIOCARDIOGRAPHY. b\) VENTRICULOGRAPHY:The usual adult volume is a single injection of 40 milliliters \(mL\) of iohexol 350 milligrams iodine/mL \(range 30 mL to 60 mL\) \[24\]\[25\]\[26\]. This may be repeated as necessary. When combined with selective coronary arteriography the total administered dose should not exceed 250 milliliters \(87.5 grams iodine\). c\) SELECTIVE CORONARY ARTERIOGRAPHY:The usual adult dose for right or left coronary arteriography is 5 milliliters \(mL\) of iohexol 350 milligrams iodine/mL \(range 3 mL to 14 mL\) per injection. |
| 肝功能異常 | 無需調整劑量  需調整劑量 |
| 腎功能異常 | 無需調整劑量  需調整劑量 |
| 懷孕用藥危分級 | 可能安全 |
| 孕期用藥建議 | N/A |
| 附帶說明 | N/A |
| 哺乳期用藥建議 | Unknown 尚未建立 |
| 附帶說明 | N/A |
| 注射劑給藥建議途徑 | IA, IV, IVP, IVPUSH, R, RECT |
| 乾粉稀釋液 | N/A |
| 輸注點滴液 | N/A |
| IVP 用法建議 | N/A |
| IVD 用法建議 | N/A |
| 注意事項 | 1.體腔使用途徑以水稀釋, 成人兒童及部位不同依1:1~1:50不等比例稀釋 2.腎功能正常病患應立即停用Meformin 48小時,待腎功能恢復後再啟用;如腎功能不佳病患,請評估病患情況,提前48小時停用Meformin. |

## Omnipaque 350mg I/mL 50mL

| 藥物代碼 | IOMN5 |
| :--- | :--- |
| 適應症 | 脊髓造影, 血管造影, 電腦斷層掃描增強造影劑, 泌尿道造影Intrathecal: Myelography; contrast enhancement for computerized tomography Intravascular: Angiocardiography, aortography, digital subtraction angiography, peripheral arteriography, excretory urography; contrast enhancement for computed tomographic imaging Oral/body cavity: Arthrography, GI tract examination, hysterosalpingography, pancreatography, cholangiopancreatography, herniography, cystourethrography; enhanced computed tomography of the abdomen |
| 副作用 | 全身溫熱感, 暫時性金屬味道, 腹部不適, 噁心, 嘔吐, 過敏性反應Cardiovascular: Asystole, arrhythmia, bradycardia, cardiopulmonary collapse, edema, heart failure, hypertension \(in patients with phenochromocytoma after intra-arterial injection\), hypotension, syncope, transient ischemic attacks, vasovagal attacks, venous thrombosis, ventricular fibrillation, ventricular tachycardiaCentral nervous system: Anxiety, confusion, dizziness, headache, loss of consciousness, seizure, vertigoDermatologic: Pruritus, rash, urticariaEndocrine & metabolic: Thyrotoxicosis exacerbationGastrointestinal: Cramping, diarrhea, nausea, salivary gland swelling, vomitingLocal: Burning sensation, pain at injection site, thrombophlebitisNeuromuscular & skeletal: Parasthesia, polyarthropathy, tremorOcular: Vision abnormalitiesRenal: Contrast-associated nephropathy, creatinine increased, renal dysfunctionRespiratory: Bronchospasm, cough, dyspnea, pulmonary edema, rhinitis, sneezingMiscellaneous: Anaphylactoid reaction, diaphoresis, hypersensitivity reactions |
| 禁忌 | Hypersensitivity to iohexol or any component of the formulation. |
| 藥物保存方式 | N/A |
| 用法用量 | Dosing is based numerous variables including: type of examination, route of administration, patient age/weight and product. Consult specific product information for detailed dosing. Intrathecal route: Myelogram a\) Lumbosacral:The usual recommended dose for use in lumbar myelography is 10 to 17 milliliters of iohexol 180 milligrams iodine/milliliter \(mgI/mL\) or 7 to 12.5 milliliters of iohexol 240 mgI/mL administered by lumbar injection. b\) Thoracic:The usual recommended dose for thoracic myelography is 6 to 12.5 milliliters of iohexol 240 milligrams iodine/milliliter \(mgI/mL\) or 6 to 10 mL of iohexol 300 mgI/mL administered by lumbar or cervical injection. c\) Cervical:For cervial myelography given by lumbar injections, the following doses have been used: 6 to 12.5 milliliters of iohexol 240 milligrams iodine/milliliter\(mgI/mL\) or 6 to 10 mL of iohexol 300 mgI/mL. If iohexol is administered by C1-2 injection, the recommended dose is 7 to 10 mL of iohexol 180 mgI/mL, 6 to 12.5 mL of iohexol 240 mgI/mL, or 4 to 10 mL of iohexol 300 mgI/mL. d\) Spinal cord:The usual dose for total columnar myelography \(lumbar injection\) is 6 to 12.5 milliliters of iohexol 240 milligrams iodine/milliliter\(mgI/mL\) or 6 to 10 mL of iohexol 300 mgI/mL. Intravascular route: CT of head The recommended dose for HEAD IMAGING is 70 to 150 milliliters of iohexol 300 milligram iodine/milliliter \(mgI/mL\) or 80 mL of iohexol 350 mgI/mL by injection or 120 to 250 mL of iohexol 240 mgI/mL by infusion. For BODY IMAGING the dose is 50 to 200 mL of iohexol 300 mgI/mL or 60 to 100 mL of iohexol 350 mgI/mL by injection. Angiocardiography a\) DOSAGE SUMMARY:Iohexol 350 milligrams iodine/milliliter is recommended for use in ANGIOCARDIOGRAPHY. b\) VENTRICULOGRAPHY:The usual adult volume is a single injection of 40 milliliters \(mL\) of iohexol 350 milligrams iodine/mL \(range 30 mL to 60 mL\) \[24\]\[25\]\[26\]. This may be repeated as necessary. When combined with selective coronary arteriography the total administered dose should not exceed 250 milliliters \(87.5 grams iodine\). c\) SELECTIVE CORONARY ARTERIOGRAPHY:The usual adult dose for right or left coronary arteriography is 5 milliliters \(mL\) of iohexol 350 milligrams iodine/mL \(range 3 mL to 14 mL\) per injection. |
| 肝功能異常 | 無需調整劑量  需調整劑量 |
| 腎功能異常 | 無需調整劑量  需調整劑量 |
| 懷孕用藥危分級 | 可能安全 |
| 孕期用藥建議 | N/A |
| 附帶說明 | N/A |
| 哺乳期用藥建議 | Unknown 尚未建立 |
| 附帶說明 | N/A |
| 注射劑給藥建議途徑 | IA, IRR, IT, IV, IVP, IVPUSH, R, RECT |
| 乾粉稀釋液 | N/A |
| 輸注點滴液 | N/A |
| IVP 用法建議 | N/A |
| IVD 用法建議 | N/A |
| 注意事項 | 1.體腔使用途徑以水稀釋, 成人兒童及部位不同依1:1~1:50不等比例稀釋 2.腎功能正常病患應立即停用Meformin 48小時,待腎功能恢復後再啟用;如腎功能不佳病患,請評估病患情況,提前48小時停用Meformin. |

